Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.WT | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Capital Markets Modernization Taskforce: Final Report 2021

<< Previous

Bullboard Posts

Next >>

Comment by Rumpl3StiltSkinon Feb 17, 2021 12:25pm

141 Views

Post# 32585282

RE:RE:RE:Capital Markets Modernization Taskforce: Final Report 2021

CAinPlap wrote: It would be interesting to see if we could put together a reddit/robinhood investorgroup to suck a few million shares from the manipulators and then set a line in the sand price that no one would sell under. Wishful thinking but a man can dream!

I think this is a great idea. We should look into it for sure, maybe after the next datapoint or two? We're getting closer to where the TLT investment story is getting compelling.

<< Previous

Bullboard Posts

Next >>

The Market Online’s Weekly Gold Report – July 3, 2024